Skip to main content
Erschienen in: Diabetologia 4/2010

01.04.2010 | Article

Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men

verfasst von: E. S. Tai, M. L. S. Tan, R. D. Stevens, Y. L. Low, M. J. Muehlbauer, D. L. M. Goh, O. R. Ilkayeva, B. R. Wenner, J. R. Bain, J. J. M. Lee, S. C. Lim, C. M. Khoo, S. H. Shah, C. B. Newgard

Erschienen in: Diabetologia | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Insulin resistance (IR) is associated with obesity, but can also develop in individuals with normal body weight. We employed comprehensive profiling methods to identify metabolic events associated with IR, while controlling for obesity.

Methods

We selected 263 non-obese (BMI approximately 24 kg/m2) Asian-Indian and Chinese men from a large cross-sectional study carried out in Singapore. Individuals taking medication for diabetes or hyperlipidaemia were excluded. Participants were separated into lower and upper tertiles of IR based on HOMA indices of ≤1.06 or ≥1.93, respectively. MS-based metabolic profiling of acylcarnitines, amino acids and organic acids was combined with hormonal and cytokine profiling in all participants.

Results

After controlling for BMI, commonly accepted risk factors for IR, including circulating fatty acids and inflammatory cytokines, did not discriminate the upper and lower quartiles of insulin sensitivity in either Asian-Indian or Chinese men. Instead, IR was correlated with increased levels of alanine, proline, valine, leucine/isoleucine, phenylalanine, tyrosine, glutamate/glutamine and ornithine, and a cluster of branched-chain and related amino acids identified by principal components analysis. These changes were not due to increased protein intake by individuals in the upper quartile of IR. Increased abdominal adiposity and leptin, and decreased adiponectin and IGF-binding protein 1 were also correlated with IR.

Conclusions/interpretation

These findings demonstrate that perturbations in amino acid homeostasis, but not inflammatory markers or NEFAs, are associated with IR in individuals of relatively low body mass.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Abbasi F, Brown BW Jr, Lamendola C, McLaughlin T, Reaven GM (2002) Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol 40:937–943CrossRefPubMed Abbasi F, Brown BW Jr, Lamendola C, McLaughlin T, Reaven GM (2002) Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol 40:937–943CrossRefPubMed
2.
Zurück zum Zitat Lee J, Ma S, Heng D et al (2007) Should central obesity be an optional or essential component of the metabolic syndrome? Ischemic heart disease risk in the Singapore Cardiovascular Cohort Study. Diabetes Care 30:343–347CrossRefPubMed Lee J, Ma S, Heng D et al (2007) Should central obesity be an optional or essential component of the metabolic syndrome? Ischemic heart disease risk in the Singapore Cardiovascular Cohort Study. Diabetes Care 30:343–347CrossRefPubMed
3.
Zurück zum Zitat Boden G, Shulman GI (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32(Suppl 3):14–23CrossRefPubMed Boden G, Shulman GI (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32(Suppl 3):14–23CrossRefPubMed
4.
Zurück zum Zitat Savage DB, Petersen KF, Shulman GI (2007) Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 87:507–520CrossRefPubMed Savage DB, Petersen KF, Shulman GI (2007) Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 87:507–520CrossRefPubMed
5.
Zurück zum Zitat Summers SA (2006) Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45:42–72CrossRefPubMed Summers SA (2006) Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45:42–72CrossRefPubMed
6.
Zurück zum Zitat Koves TR, Ussher JR, Noland RC et al (2008) Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 7:45–56CrossRefPubMed Koves TR, Ussher JR, Noland RC et al (2008) Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 7:45–56CrossRefPubMed
7.
Zurück zum Zitat Muoio DM, Newgard CB (2008) Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 9:193–205CrossRefPubMed Muoio DM, Newgard CB (2008) Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 9:193–205CrossRefPubMed
8.
Zurück zum Zitat Schenk S, Saberi M, Olefsky JM (2008) Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 118:2992–3002CrossRefPubMed Schenk S, Saberi M, Olefsky JM (2008) Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 118:2992–3002CrossRefPubMed
9.
Zurück zum Zitat Chevalier S, Marliss EB, Morais JA, Lamarche M, Gougeon R (2005) Whole-body protein anabolic response is resistant to the action of insulin in obese women. Am J Clin Nutr 82:355–365PubMed Chevalier S, Marliss EB, Morais JA, Lamarche M, Gougeon R (2005) Whole-body protein anabolic response is resistant to the action of insulin in obese women. Am J Clin Nutr 82:355–365PubMed
10.
Zurück zum Zitat Felig P, Marliss E, Cahill GF Jr (1969) Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 281:811–816PubMed Felig P, Marliss E, Cahill GF Jr (1969) Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 281:811–816PubMed
11.
Zurück zum Zitat Gougeon R, Morais JA, Chevalier S, Pereira S, Lamarche M, Marliss EB (2008) Determinants of whole-body protein metabolism in subjects with and without type 2 diabetes. Diabetes Care 31:128–133CrossRefPubMed Gougeon R, Morais JA, Chevalier S, Pereira S, Lamarche M, Marliss EB (2008) Determinants of whole-body protein metabolism in subjects with and without type 2 diabetes. Diabetes Care 31:128–133CrossRefPubMed
12.
Zurück zum Zitat Marliss EB, Gougeon R (2002) Diabetes mellitus, lipidus et … proteinus! Diabetes Care 25:1474–1476CrossRefPubMed Marliss EB, Gougeon R (2002) Diabetes mellitus, lipidus et … proteinus! Diabetes Care 25:1474–1476CrossRefPubMed
13.
Zurück zum Zitat Pereira S, Marliss EB, Morais JA, Chevalier S, Gougeon R (2008) Insulin resistance of protein metabolism in type 2 diabetes. Diabetes 57:56–63CrossRefPubMed Pereira S, Marliss EB, Morais JA, Chevalier S, Gougeon R (2008) Insulin resistance of protein metabolism in type 2 diabetes. Diabetes 57:56–63CrossRefPubMed
14.
Zurück zum Zitat Newgard CB, An J, Bain JR et al (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9:311–326CrossRefPubMed Newgard CB, An J, Bain JR et al (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9:311–326CrossRefPubMed
15.
Zurück zum Zitat Huffman KM, Shah SH, Stevens RD et al (2009) Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care 32:1678–1683CrossRefPubMed Huffman KM, Shah SH, Stevens RD et al (2009) Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care 32:1678–1683CrossRefPubMed
16.
Zurück zum Zitat Zimmet P, Alberti KG, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782–787CrossRefPubMed Zimmet P, Alberti KG, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782–787CrossRefPubMed
17.
Zurück zum Zitat Deurenberg-Yap M, Chew SK, Lin VF, Tan BY, van Staveren WA, Deurenberg P (2001) Relationships between indices of obesity and its co-morbidities in multi-ethnic Singapore. Int J Obes Relat Metab Disord 25:1554–1562CrossRefPubMed Deurenberg-Yap M, Chew SK, Lin VF, Tan BY, van Staveren WA, Deurenberg P (2001) Relationships between indices of obesity and its co-morbidities in multi-ethnic Singapore. Int J Obes Relat Metab Disord 25:1554–1562CrossRefPubMed
18.
Zurück zum Zitat Ko GT, Chan JC, Cockram CS, Woo J (1999) Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese. Int J Obes Relat Metab Disord 23:1136–1142CrossRefPubMed Ko GT, Chan JC, Cockram CS, Woo J (1999) Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese. Int J Obes Relat Metab Disord 23:1136–1142CrossRefPubMed
19.
Zurück zum Zitat Thai AC, Yeo PP, Lun KC et al (1990) Diabetes mellitus and its chronic complications in Singapore: an increasing healthcare problem. Ann Acad Med Singapore 19:517–523PubMed Thai AC, Yeo PP, Lun KC et al (1990) Diabetes mellitus and its chronic complications in Singapore: an increasing healthcare problem. Ann Acad Med Singapore 19:517–523PubMed
20.
Zurück zum Zitat Cutter J, Tan BY, Chew SK (2001) Levels of cardiovascular disease risk factors in Singapore following a national intervention programme. Bull World Health Organ 79:908–915PubMed Cutter J, Tan BY, Chew SK (2001) Levels of cardiovascular disease risk factors in Singapore following a national intervention programme. Bull World Health Organ 79:908–915PubMed
21.
Zurück zum Zitat Tai ES, Lim SC, Chew SK, Tan BY, Tan CE (2000) Homeostasis model assessment in a population with mixed ethnicity: the 1992 Singapore National Health Survey. Diabetes Res Clin Pract 49:159–168CrossRefPubMed Tai ES, Lim SC, Chew SK, Tan BY, Tan CE (2000) Homeostasis model assessment in a population with mixed ethnicity: the 1992 Singapore National Health Survey. Diabetes Res Clin Pract 49:159–168CrossRefPubMed
22.
Zurück zum Zitat Tan CE, Emmanuel SC, Tan BY, Jacob E (1999) Prevalence of diabetes and ethnic differences in cardiovascular risk factors. The 1992 Singapore National Health Survey. Diabetes Care 22:241–247CrossRefPubMed Tan CE, Emmanuel SC, Tan BY, Jacob E (1999) Prevalence of diabetes and ethnic differences in cardiovascular risk factors. The 1992 Singapore National Health Survey. Diabetes Care 22:241–247CrossRefPubMed
23.
Zurück zum Zitat Yeo KK, Tai BC, Heng D et al (2006) Ethnicity modifies the association between diabetes mellitus and ischaemic heart disease in Chinese, Malays and Asian Indians living in Singapore. Diabetologia 49:2866–2873CrossRefPubMed Yeo KK, Tai BC, Heng D et al (2006) Ethnicity modifies the association between diabetes mellitus and ischaemic heart disease in Chinese, Malays and Asian Indians living in Singapore. Diabetologia 49:2866–2873CrossRefPubMed
24.
Zurück zum Zitat Nang EE, Khoo CM, Tai ES et al (2009) Is there a clear threshold for fasting plasma glucose that differentiates between those with and without neuropathy and chronic kidney disease?: the Singapore Prospective Study Program. Am J Epidemiol 169:1454–1462CrossRefPubMed Nang EE, Khoo CM, Tai ES et al (2009) Is there a clear threshold for fasting plasma glucose that differentiates between those with and without neuropathy and chronic kidney disease?: the Singapore Prospective Study Program. Am J Epidemiol 169:1454–1462CrossRefPubMed
25.
Zurück zum Zitat Hughes K, Yeo PP, Lun KC et al (1990) Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. II. Differences in risk factor levels. J Epidemiol Community Health 44:29–35CrossRefPubMed Hughes K, Yeo PP, Lun KC et al (1990) Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. II. Differences in risk factor levels. J Epidemiol Community Health 44:29–35CrossRefPubMed
26.
Zurück zum Zitat Hughes K, Aw TC, Kuperan P, Choo M (1997) Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Community Health 51:394–399CrossRefPubMed Hughes K, Aw TC, Kuperan P, Choo M (1997) Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Community Health 51:394–399CrossRefPubMed
27.
Zurück zum Zitat Deurenberg-Yap M, Li T, Tan WL, van Staveren WA, Chew SK, Deurenberg P (2001) Can dietary factors explain differences in serum cholesterol profiles among different ethnic groups (Chinese, Malays and Indians) in Singapore? Asia Pac J Clin Nutr 10:39–45CrossRefPubMed Deurenberg-Yap M, Li T, Tan WL, van Staveren WA, Chew SK, Deurenberg P (2001) Can dietary factors explain differences in serum cholesterol profiles among different ethnic groups (Chinese, Malays and Indians) in Singapore? Asia Pac J Clin Nutr 10:39–45CrossRefPubMed
28.
Zurück zum Zitat Deurenberg-Yap M, Li T, Tan WL, van Staveren WA, Deurenberg P (2000) Validation of a semiquantitative food frequency questionnaire for estimation of intakes of energy, fats and cholesterol among Singaporeans. Asia Pac J Clin Nutr 9:282–288CrossRef Deurenberg-Yap M, Li T, Tan WL, van Staveren WA, Deurenberg P (2000) Validation of a semiquantitative food frequency questionnaire for estimation of intakes of energy, fats and cholesterol among Singaporeans. Asia Pac J Clin Nutr 9:282–288CrossRef
29.
Zurück zum Zitat Anon (1994) Food consumption study 1993. Food and Nutrition Department, Ministry of Health, Singapore Anon (1994) Food consumption study 1993. Food and Nutrition Department, Ministry of Health, Singapore
30.
Zurück zum Zitat Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L (1986) A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124:453–469PubMed Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L (1986) A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124:453–469PubMed
31.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed
32.
Zurück zum Zitat An J, Muoio DM, Shiota M et al (2004) Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat Med 10:268–274CrossRefPubMed An J, Muoio DM, Shiota M et al (2004) Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat Med 10:268–274CrossRefPubMed
33.
Zurück zum Zitat Ferrara CT, Wang P, Neto EC et al (2008) Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling. PLoS Genet 4:e1000034CrossRefPubMed Ferrara CT, Wang P, Neto EC et al (2008) Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling. PLoS Genet 4:e1000034CrossRefPubMed
34.
Zurück zum Zitat Wu JY, Kao HJ, Li SC et al (2004) ENU mutagenesis identifies mice with mitochondrial branched-chain aminotransferase deficiency resembling human maple syrup urine disease. J Clin Invest 113:434–440PubMed Wu JY, Kao HJ, Li SC et al (2004) ENU mutagenesis identifies mice with mitochondrial branched-chain aminotransferase deficiency resembling human maple syrup urine disease. J Clin Invest 113:434–440PubMed
35.
Zurück zum Zitat Shah SH, Hauser ER, Bain JR et al (2009) High heritability of metabolomic profiles in families burdened with premature cardiovascular disease. Mol Syst Biol 5:258CrossRefPubMed Shah SH, Hauser ER, Bain JR et al (2009) High heritability of metabolomic profiles in families burdened with premature cardiovascular disease. Mol Syst Biol 5:258CrossRefPubMed
36.
Zurück zum Zitat Patterson BW, Horowitz JF, Wu G et al (2001) Regional adipose tissue amino acid metabolism in lean and obese women. Am J Physiol Endocrinol Metabol 282:E931–E936 Patterson BW, Horowitz JF, Wu G et al (2001) Regional adipose tissue amino acid metabolism in lean and obese women. Am J Physiol Endocrinol Metabol 282:E931–E936
37.
Zurück zum Zitat She P, van Horn C, Reid T et al (2007) Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metabol 293:E1552–E1563CrossRef She P, van Horn C, Reid T et al (2007) Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metabol 293:E1552–E1563CrossRef
38.
Zurück zum Zitat Roubenoff R (2000) Sarcopenic obesity: does muscle loss cause fat gain? Lessons from rheumatoid arthritis and osteoarthritis. Ann N Y Acad Sci 904:553–557PubMed Roubenoff R (2000) Sarcopenic obesity: does muscle loss cause fat gain? Lessons from rheumatoid arthritis and osteoarthritis. Ann N Y Acad Sci 904:553–557PubMed
39.
Zurück zum Zitat Abbatecola AM, Ferrucci L, Ceda G et al (2005) Insulin resistance and muscle strength in older persons. J Gerontol Ser A Biol Sci Med Sci 60:1278–1282 Abbatecola AM, Ferrucci L, Ceda G et al (2005) Insulin resistance and muscle strength in older persons. J Gerontol Ser A Biol Sci Med Sci 60:1278–1282
40.
Zurück zum Zitat Guillet C, Boirie Y (2005) Insulin resistance: a contributing factor to age-related muscle mass loss? Diabetes Metab 31(Spec No. 2):5S20–5S26CrossRefPubMed Guillet C, Boirie Y (2005) Insulin resistance: a contributing factor to age-related muscle mass loss? Diabetes Metab 31(Spec No. 2):5S20–5S26CrossRefPubMed
41.
Zurück zum Zitat Nomura T, Ikeda Y, Nakao S et al (2007) Muscle strength is a marker of insulin resistance in patients with type 2 diabetes: a pilot study. Endocr J 54:791–796CrossRefPubMed Nomura T, Ikeda Y, Nakao S et al (2007) Muscle strength is a marker of insulin resistance in patients with type 2 diabetes: a pilot study. Endocr J 54:791–796CrossRefPubMed
42.
Zurück zum Zitat Park SW, Goodpaster BH, Strotmeyer ES et al (2007) Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care 30:1507–1512CrossRefPubMed Park SW, Goodpaster BH, Strotmeyer ES et al (2007) Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care 30:1507–1512CrossRefPubMed
43.
Zurück zum Zitat Kuk JL, Kilpatrick K, Davidson LE et al (2008) Whole body skeletal muscle mass is not related to glucose tolerance or insulin sensitivity in overweight and obese men and women. Appl Physiol Nutr Metab 33:769–774CrossRefPubMed Kuk JL, Kilpatrick K, Davidson LE et al (2008) Whole body skeletal muscle mass is not related to glucose tolerance or insulin sensitivity in overweight and obese men and women. Appl Physiol Nutr Metab 33:769–774CrossRefPubMed
44.
Zurück zum Zitat Sparrow D, Borkan GA, Gerzof SG et al (1986) Relationship of fat distribution to glucose tolerance. Results of computed tomography in male participants of the Normative Aging Study. Diabetes 35:411–415CrossRefPubMed Sparrow D, Borkan GA, Gerzof SG et al (1986) Relationship of fat distribution to glucose tolerance. Results of computed tomography in male participants of the Normative Aging Study. Diabetes 35:411–415CrossRefPubMed
45.
Zurück zum Zitat Roubenoff R, Freeman LM, Smith DE, Abad LW, Dinarello CA, Kehayias JJ (1997) Adjuvant arthritis as a model of inflammatory cachexia. Arthritis Rheum 40:534–539CrossRefPubMed Roubenoff R, Freeman LM, Smith DE, Abad LW, Dinarello CA, Kehayias JJ (1997) Adjuvant arthritis as a model of inflammatory cachexia. Arthritis Rheum 40:534–539CrossRefPubMed
46.
Zurück zum Zitat Schrager MA, Metter EJ, Simonsick E et al (2007) Sarcopenic obesity and inflammation in the InCHIANTI Study. J Appl Physiol 102:919–925CrossRefPubMed Schrager MA, Metter EJ, Simonsick E et al (2007) Sarcopenic obesity and inflammation in the InCHIANTI Study. J Appl Physiol 102:919–925CrossRefPubMed
47.
Zurück zum Zitat Thyfault JP, Kraus RM, Hickner RC et al (2004) Impaired plasma fatty acid oxidation in extremely obese women. Am J Physiol Endorinol Metabol 287:E1076–E1081CrossRef Thyfault JP, Kraus RM, Hickner RC et al (2004) Impaired plasma fatty acid oxidation in extremely obese women. Am J Physiol Endorinol Metabol 287:E1076–E1081CrossRef
48.
Zurück zum Zitat Blaak EE, Wolffenbuttel BH, Saris WH et al (2001) Weight reduction and the impaired plasma-derived free fatty acid oxidation in type 2 diabetic subjects. J Clin Endocrinol Metabol 86:1638–1644CrossRef Blaak EE, Wolffenbuttel BH, Saris WH et al (2001) Weight reduction and the impaired plasma-derived free fatty acid oxidation in type 2 diabetic subjects. J Clin Endocrinol Metabol 86:1638–1644CrossRef
49.
Zurück zum Zitat Brismar K, Fernqvist-Forbes E, Wahren J, Hall K (1994) Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metabol 79:872–878CrossRef Brismar K, Fernqvist-Forbes E, Wahren J, Hall K (1994) Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metabol 79:872–878CrossRef
50.
Zurück zum Zitat Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI (2005) Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54:603–608CrossRefPubMed Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI (2005) Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54:603–608CrossRefPubMed
51.
Zurück zum Zitat Amati F, Dube JJ, Coen PM et al (2009) Physical inactivity and obesity underlie the insulin resistance of aging. Diabetes Care 32:1547–1549CrossRefPubMed Amati F, Dube JJ, Coen PM et al (2009) Physical inactivity and obesity underlie the insulin resistance of aging. Diabetes Care 32:1547–1549CrossRefPubMed
Metadaten
Titel
Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men
verfasst von
E. S. Tai
M. L. S. Tan
R. D. Stevens
Y. L. Low
M. J. Muehlbauer
D. L. M. Goh
O. R. Ilkayeva
B. R. Wenner
J. R. Bain
J. J. M. Lee
S. C. Lim
C. M. Khoo
S. H. Shah
C. B. Newgard
Publikationsdatum
01.04.2010
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 4/2010
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1637-8

Weitere Artikel der Ausgabe 4/2010

Diabetologia 4/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.